PDS Biotechnology Corporation (PDSB) Stock Total Returns
Growth of $10,000 chart
2021-06-03 to 2026-06-03 to
$
%
%
Loading chart…
Investment Performance
Final Value
$956
Total Return
-90.44%
CAGR
-37.48%
Dividends
$0.00
Yield on Cost
0.00%
Rolling Returns
1-Month (21 Trading Days)
| Average | -0.93% |
| Median | -5.37% |
| Best | +134.67% |
| Worst | -49.60% |
| % of Windows Positive | 39.0% |
1-Year (252 Trading Days)
| Average | -31.92% |
| Median | -45.67% |
| Best | +153.91% |
| Worst | -82.20% |
| % of Windows Positive | 21.7% |
3-Year (756 Trading Days)
| Average | -77.80% |
| Median | -77.71% |
| Best | -47.21% |
| Worst | -92.97% |
| % of Windows Positive | 0.0% |
Risk Metrics
| Maximum Drawdown | -96.86% |
| Average Drawdown | -71.05% |
| Drawdown Duration | 1177 Trading Days (Unrecovered) |
| Sortino Ratio | -0.09 |
| Calmar Ratio | -0.39 |
| CVaR (5%) | -11.99% |
Yearly Returns
| Year | Percentage | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|
| 2026 partial | +40.26% (+123.10% ann.) | +$4026.00 | $0.00 | $0.00 | $0.00 |
| 2025 | -52.76% | $5276.14 | $0.00 | $0.00 | $0.00 |
| 2024 | -67.20% | $6720.31 | $0.00 | $0.00 | $0.00 |
| 2023 | -62.35% | $6234.84 | $0.00 | $0.00 | $0.00 |
| 2022 | +62.96% | +$6296.32 | $0.00 | $0.00 | $0.00 |
| 2021 | +278.51% | +$27850.61 | $0.00 | $0.00 | $0.00 |
| 2020 | -19.25% | $1924.56 | $0.00 | $0.00 | $0.00 |
| 2019 | -58.72% | $5872.27 | $0.00 | $0.00 | $0.00 |
| 2018 partial | -75.50% (-84.24% ann.) | $7549.62 | $0.00 | $0.00 | $0.00 |
Market Regimes
about| Regime | Period | Percentage | Annual | Abs. Return | Dividends | Taxes | Trans. Costs |
|---|---|---|---|---|---|---|---|
| Secular stagnation / QE / low inflation / duration bull partial | March 28, 2018 – February 19, 2020 | -94.77% | -78.89% | $9477.10 | $0.00 | $0.00 | $0.00 |
| Pandemic shock / liquidity crash | February 20, 2020 – March 23, 2020 | -48.90% | -99.95% | $4890.42 | $0.00 | $0.00 | $0.00 |
| Policy bazooka / monetary euphoria | March 24, 2020 – November 6, 2020 | +252.60% | +659.61% | +$25259.87 | $0.00 | $0.00 | $0.00 |
| Reopening reflation / fiscal boom / supply bottlenecks | November 9, 2020 – November 29, 2021 | +363.23% | +328.20% | +$36323.29 | $0.00 | $0.00 | $0.00 |
| Inflation shock / duration crash / aggressive tightening | November 30, 2021 – November 9, 2022 | -46.19% | -48.21% | $4619.29 | $0.00 | $0.00 | $0.00 |
| Disinflation rebound / AI-led narrow bull / higher-for-longer | November 10, 2022 – September 17, 2024 | -43.58% | -26.57% | $4358.05 | $0.00 | $0.00 | $0.00 |
| Disinflationary easing / resilient growth / AI capex under oil-shock test partial | September 18, 2024 – June 3, 2026 | -64.82% | -45.80% | $6482.13 | $0.00 | $0.00 | $0.00 |
Dividend History
| Date | Per Share | Yield % |
|---|---|---|
| Total | 0 payments |
No dividends recorded.
All calculations use split-adjusted closing prices. Dividends are reinvested on the ex-dividend date at that day's closing price.
For each rolling window, returns are calculated at every possible starting point:
return = (value[i] ÷ value[i − windowSize] − 1) × 100
- Windows
- 1-month = 21 trading days, 1-year = 252 trading days, 3-year = 756 trading days.
- Statistics
- Average: arithmetic mean. Median: middle value when sorted. Best / Worst: max and min. % Positive: share of windows with return > 0.
The series is segmented by calendar year:
return = (endValue ÷ startValue − 1) × 100
startValue is the last value of the prior year (or the first value for the initial year). Partial first/last years are flagged. Dividends, taxes, and transaction costs are scaled proportionally to the initial investment.